These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 31903153

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.
    Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA.
    Cancer Res; 2002 Oct 01; 62(19):5443-50. PubMed ID: 12359751
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer.
    Tasaki Y, Suzuki M, Katsushima K, Shinjo K, Iijima K, Murofushi Y, Naiki-Ito A, Hayashi K, Qiu C, Takahashi A, Tanaka Y, Kawaguchi T, Sugawara M, Kataoka T, Naito M, Miyata K, Kataoka K, Noda T, Gao W, Kataoka H, Takahashi S, Kimura K, Kondo Y.
    Cancer Res; 2021 Apr 01; 81(7):1654-1666. PubMed ID: 33648930
    [Abstract] [Full Text] [Related]

  • 48. Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
    Nicholson LJ, Smith PR, Hiller L, Szlosarek PW, Kimberley C, Sehouli J, Koensgen D, Mustea A, Schmid P, Crook T.
    Int J Cancer; 2009 Sep 15; 125(6):1454-63. PubMed ID: 19533750
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y, Lu F, Fei Q, Yu X, Xiong P, Yu X, Dang Y, Hou Z, Lin W, Lin X, Zhang Z, Pan M, Huang H.
    J Hematol Oncol; 2019 Nov 27; 12(1):124. PubMed ID: 31771616
    [Abstract] [Full Text] [Related]

  • 54. Combination of arginine deprivation with TRAIL treatment as a targeted-therapy for mesothelioma.
    Wangpaichitr M, Wu C, Bigford G, Theodoropoulos G, You M, Li YY, Verona-Santos J, Feun LG, Nguyen DM, Savaraj N.
    Anticancer Res; 2014 Dec 27; 34(12):6991-9. PubMed ID: 25503125
    [Abstract] [Full Text] [Related]

  • 55. Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma.
    Sahu N, Chan E, Chu F, Pham T, Koeppen H, Forrest W, Merchant M, Settleman J.
    Mol Cancer Ther; 2017 Sep 27; 16(9):1729-1738. PubMed ID: 28619758
    [Abstract] [Full Text] [Related]

  • 56. Cyclic adenosine monophosphate-induced argininosuccinate synthase 1 expression is essential during mouse decidualization.
    Huang Z, Wang TS, Zhao YC, Zuo RJ, Deng WB, Chi YJ, Yang ZM.
    Mol Cell Endocrinol; 2014 May 05; 388(1-2):20-31. PubMed ID: 24556046
    [Abstract] [Full Text] [Related]

  • 57. A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma.
    Hall PE, Lewis R, Syed N, Shaffer R, Evanson J, Ellis S, Williams M, Feng X, Johnston A, Thomson JA, Harris FP, Jena R, Matys T, Jefferies S, Smith K, Wu BW, Bomalaski JS, Crook T, O'Neill K, Paraskevopoulos D, Khadeir RS, Sheaff M, Pacey S, Plowman PN, Szlosarek PW.
    Clin Cancer Res; 2019 May 01; 25(9):2708-2716. PubMed ID: 30796035
    [Abstract] [Full Text] [Related]

  • 58. An epigenetic approach to pancreatic cancer treatment: the prospective role of histone deacetylase inhibitors.
    Tinari N, De Tursi M, Grassadonia A, Zilli M, Stuppia L, Iacobelli S, Natoli C.
    Curr Cancer Drug Targets; 2012 May 01; 12(4):439-52. PubMed ID: 22309455
    [Abstract] [Full Text] [Related]

  • 59. Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase.
    Kelly MP, Jungbluth AA, Wu BW, Bomalaski J, Old LJ, Ritter G.
    Br J Cancer; 2012 Jan 17; 106(2):324-32. PubMed ID: 22134507
    [Abstract] [Full Text] [Related]

  • 60. Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase.
    Yoon CY, Shim YJ, Kim EH, Lee JH, Won NH, Kim JH, Park IS, Yoon DK, Min BH.
    Int J Cancer; 2007 Feb 15; 120(4):897-905. PubMed ID: 17096330
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.